Table 2. Histological findings in patients with post-transplantation EPS and classical EPS; Fibrosis (0, 1 vs. 2, 3), Fibroblast-like-cells (FLC) (0, 1 vs. 2, 3), Exudation (0, 1 vs. 2, 3), Mesothelial denudation (0 vs. 1), Acellular areas (0 vs. 1), Cellularity (0, 1 vs. 2, 3), Vessel density (0, 1 vs. 2, 3), Acute inflammation (0, 1 vs. 2, 3), Chronic inflammation (0, 1 vs. 2, 3), Vasculopathy (0 vs. 1), Hemorrhage (0, 1 vs. 2, 3), Fibrin deposits (0, 1 vs. 2, 3), Calcification (0 vs. 1), Iron deposits (0 vs. 1), Ossification (0 vs. 1), Podoplanin vascular (0, 1 vs. 2, 3), Podoplanin avscular (0, 1 vs. 2, 3).
Variable | PT-EPS (n = 28) | cEPS (n = 28) | p |
Fibrosis | 1/27 | 2/26 | 1 |
FLC | 14/14 | 10/18 | 0.4 |
Exudation | 12/16 | 14/14 | 0.8 |
Mesothelial denudation | 0/28 | 0/28 | 1 |
Acellular areas | 16/12 | 21/7 | 0.3 |
Cellularity | 12/16 | 8/20 | 0.4 |
Vessel density | 9/19 | 5/23 | 0.4 |
Acute inflammation | 24/4 | 23/5 | 0.3 |
Chronic inflammation | 16/12 | 13/15 | 1 |
Vasculopathy | 5/23 | 6/22 | 1 |
Hemorrhage | 17/11 | 15/13 | 0.8 |
Fibrin deposits | 11/17 | 10/18 | 1 |
Calcification | 25/3 | 26/2 | 1 |
Iron deposits | 11/17 | 10/18 | 1 |
Ossification | 0/0 | 0/0 | 1 |
Podoplanin vascular | 16/12 | 17/11 | 1 |
Podoplanin avascular | 11/17 | 10/18 | 1 |